• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Sarasota tech firm sells software unit for $925M

Share:

July 7, 2018

Highlights on this story:
  • Thermo Fisher will pay $925 million in cash for Gatan Inc.
  • Roper, a Sarasota software and engineered products firm, that makes instruments and software for electron microscopes bought Gatan 22 years ago, paying about $51.8 million.
  • For 2018, Gatan is expected to generate about $150 million in revenue.

Roper Technologies Inc. agreed to sell a business unit that makes instruments and software for electron microscopes to Thermo Fisher Scientific Inc.

Thermo Fisher will pay $925 million in cash for Gatan Inc., a wholly owned subsidiary of Roper, a press release said.

Roper,  a Sarasota software and engineered products firm, bought Gatan 22 years ago, paying about $51.8 million, according to a May 1996 Wall Street Journal report about the deal. Gatan was expected to report revenue of about $26.5 million in revenue for the fiscal year beginning May 31, 1996, the Journal said.

For 2018, Gatan is expected to generate about $150 million in revenue.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Gatan is headquartered in Pleasanton, California and has key manufacturing operations in Warrendale, Pennsylvania. Gatan has about 320 employees globally.

Thermo Fisher, a life sciences firm headquartered in Waltham, Massachusetts, “is the perfect home for Gatan,” Brian Jellison, Roper’s chairman, president and CEO, said in a statement.

The Gatan transaction is expected to close by the end of 2018.

Roper is an active mergers and acquisitions player, but has been more of a buyer than a seller for the past several years. In 2017, the company completed four acquisitions for an aggregate purchase price of $152 million, and sold a product line in its energy systems and controls segment for $10.4 million, according to filings with the U.S. Securities and Exchange Commission.

Roper did its biggest deal ever in 2016, when it paid $2.8 billion for software and information solutions company Deltek, one of six deals Roper completed that year.

Roper closed its most recent deal, the $1.1 billion purchase of PowerPlan, a software company, on June 4.

Date: July 9, 2018

Source: Business Journal

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Return-to-Work App Uses Voice Samples to Screen for Respiratory Illness SymptomsReturn-to-Work App Uses Voice Samples to Screen for Respiratory Illness Symptoms
  • HIMSS Insights Special Edition – APAC Digital Health TrendbarometerHIMSS Insights Special Edition – APAC Digital Health Trendbarometer
  • Alfie Health Raises $2.1M for AI-Powered, Virtual Obesity ClinicAlfie Health Raises $2.1M for AI-Powered, Virtual Obesity Clinic
  • Harrison Street Acquires Osborn Triangle, a State-of-the-Art Office and Laboratory Complex Located in Cambridge, Mass.Harrison Street Acquires Osborn Triangle, a State-of-the-Art Office and Laboratory Complex Located in Cambridge, Mass.
  • EUSA Pharma Announces Sale of Critical Care Business to SERB PharmaceuticalsEUSA Pharma Announces Sale of Critical Care Business to SERB Pharmaceuticals
  • Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 TestCue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
  • Haleon Will Launch with $12b+ Debt as New GSK Gains MomentumHaleon Will Launch with $12b+ Debt as New GSK Gains Momentum
  • NeuroMetrix Signs DPNCheck® Collaboration Agreement with BiomedixNeuroMetrix Signs DPNCheck® Collaboration Agreement with Biomedix

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications